Concepedia

Azadeh Hosseini‐Tabatabaei

AH

14

Publications

723

Citations

13

H-Index

2008

Active since

Affiliations

University of British Columbia(Current)

Tehran University of Medical Sciences

The University of Texas Health Science Center at San Antonio

Azadeh Hosseini‐Tabatabaei is an author at University of British Columbia specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

2008–2024

14

Publications

14

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

Arun J. Sanyal, Pierre Bédossa, Mandy Fraessdorf et al. · New England Journal of Medicine · 2024 · 346 citations

Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal

Reza B. Jalili, Alireza M. Rezakhanlou, Azadeh Hosseini‐Tabatabaei et al. · Journal of Cellular Physiology · 2010 · 82 citations

On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells

Hadi Esmaily, Azadeh Hosseini‐Tabatabaei, Reza Rahimian et al. · Open Life Sciences · 2008 · 43 citations · Full text

, , +15

Potassium Channel Openers and Improvement of Toxic Stress: Do they have Role in the Management of Inflammatory Bowel Disease?

Azadeh Hosseini‐Tabatabaei, Mohammad Abdollahı · Inflammation & Allergy - Drug Targets · 2008 · 36 citations

, , +13

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis

Eric Lawitz, Mandy Fraessdorf, Guy Neff et al. · Journal of Hepatology · 2024 · 36 citations · Full text

Rows per page

1–5 of 14